The CATHERINE trial begins as the first clinical trial of an innovative CAR-T therapy that triggers a dual anti-tumour response in HER2+ solid tumours

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...

Read more

A new treatment is effective for advanced HER2-low breast cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO)-IDIBELL and the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, par...

Read more

Se identifica por primera vez un gen esencial en la creación de resistencias al tratamiento del cáncer de mama HER2

by INCLIVA

El estudio preclínico realizado en células confirma que dos micro-RNAs, miR-26a y miR-30b, intervienen en la respuesta del organismo al tratamiento habitual de uno de los tipos de cáncer de mama m

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream